Eli Lilly's Insulin Price Cap Deal Collapses After Cert. Denial
By Hailey Konnath · April 16, 2024, 11:08 PM EDT
Eli Lilly & Co. and insulin buyers have called off a proposed nationwide settlement that would've capped insulin prices and been worth up to $500 million over several years, a decision...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login